| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1003693231 |
| P356 | DOI | 10.1038/SJ.ONC.1202548 |
| P8608 | Fatcat ID | release_3rqkwg27cbbitf74trd372xphq |
| P698 | PubMed publication ID | 9872325 |
| P5875 | ResearchGate publication ID | 13416771 |
| P2093 | author name string | D H Price | |
| J Peng | |||
| X Graña | |||
| J Garriga | |||
| M Parreño | |||
| E E Henderson | |||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | T cell activation | Q14863969 |
| P304 | page(s) | 3093-102 | |
| P577 | publication date | 1998-12-17 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Upregulation of cyclin T1/CDK9 complexes during T cell activation | |
| P478 | volume | 17 |
| Q24310643 | Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription |
| Q28115623 | Activation of MyoD-dependent transcription by cdk9/cyclin T2 |
| Q35746236 | Activation of P-TEFb at sites of dual HIV/TB infection, and inhibition of MTB-induced HIV transcriptional activation by the inhibitor of CDK9, Indirubin-3'-monoxime |
| Q39606992 | Activation of human immunodeficiency virus transcription in T cells revisited: NF-kappaB p65 stimulates transcriptional elongation |
| Q33836069 | Antiapoptotic function of Cdk9 (TAK/P-TEFb) in U937 promonocytic cells |
| Q28292152 | Antiviral activity of CYC202 in HIV-1-infected cells |
| Q39591738 | Binding of Tat to TAR and recruitment of positive transcription elongation factor b occur independently in bovine immunodeficiency virus |
| Q42812732 | CDK9 has the intrinsic property to shuttle between nucleus and cytoplasm, and enhanced expression of cyclin T1 promotes its nuclear localization |
| Q35161639 | CDK9 is constitutively expressed throughout the cell cycle, and its steady-state expression is independent of SKP2. |
| Q33302108 | Cellular mRNA activates transcription elongation by displacing 7SK RNA. |
| Q38333164 | Closing loop base pairs in RNA loop-loop complexes: structural behavior, interaction energy and solvation analysis through molecular dynamics simulations |
| Q34121518 | Complexities in the development of cyclin-dependent kinase inhibitor drugs |
| Q37645582 | Curing HIV: Pharmacologic approaches to target HIV-1 latency |
| Q28138707 | Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription |
| Q24301811 | Cyclin K inhibits HIV-1 gene expression and replication by interfering with cyclin-dependent kinase 9 (CDK9)-cyclin T1 interaction in Nef-dependent manner |
| Q42052356 | Cyclin T1 and CDK9 T-loop phosphorylation are downregulated during establishment of HIV-1 latency in primary resting memory CD4+ T cells. |
| Q39681689 | Cyclin T1 expression is mediated by a complex and constitutively active promoter and does not limit human immunodeficiency virus type 1 Tat function in unstimulated primary lymphocytes |
| Q40495577 | Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells |
| Q36796438 | Cyclins and cell cycle control in cancer and disease |
| Q38120534 | Deregulations in the cyclin-dependent kinase-9-related pathway in cancer: implications for drug discovery and development |
| Q40642204 | Differential activation of Tat variants in mitogen-stimulated cells: implications for HIV-1 postintegration latency |
| Q36419687 | Direct inhibition of CDK9 blocks HIV-1 replication without preventing T-cell activation in primary human peripheral blood lymphocytes |
| Q37269112 | Dormancy activation mechanism of tracheal stem cells |
| Q38557763 | Effects of prostratin on Cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+ T cells |
| Q64120094 | Entry of Polarized Effector Cells into Quiescence Forces HIV Latency |
| Q39933477 | Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency |
| Q33910799 | Flavopiridol inhibits P-TEFb and blocks HIV-1 replication |
| Q37368973 | Functional evolution of cyclin-dependent kinases. |
| Q46688122 | Genome-wide annotation and expression profiling of cell cycle regulatory genes in Chlamydomonas reinhardtii. |
| Q33711447 | HIV-1 Tat: coping with negative elongation factors |
| Q38273477 | HIV-1 replication and latency are regulated by translational control of cyclin T1 |
| Q45395775 | Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells |
| Q59357225 | Host and Viral Factors Influencing Interplay between the Macrophage and HIV-1 |
| Q34228694 | Human cytomegalovirus infection induces specific hyperphosphorylation of the carboxyl-terminal domain of the large subunit of RNA polymerase II that is associated with changes in the abundance, activity, and localization of cdk9 and cdk7. |
| Q42802816 | Identification of a novel isoform of Cdk9. |
| Q41274276 | Identification of novel CDK9 and Cyclin T1-associated protein complexes (CCAPs) whose siRNA depletion enhances HIV-1 Tat function |
| Q36334152 | Increased cyclin T1 expression as a favorable prognostic factor in treating gastric adenocarcinoma |
| Q33849629 | Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines |
| Q36850296 | Inhibition of HIV-1 transcription and replication by a newly identified cyclin T1 splice variant. |
| Q28344365 | Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors |
| Q24548261 | Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome |
| Q47844049 | Isolation and characterization of the human cyclin T1 promoter |
| Q40118214 | Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR. |
| Q34033135 | NF-kappa B and HIV: linking viral and immune activation |
| Q33602605 | Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat |
| Q89782162 | P-TEFb as A Promising Therapeutic Target |
| Q29620167 | P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II |
| Q38008733 | Perspective of cyclin-dependent kinase 9 (CDK9) as a drug target. |
| Q36953714 | Positive cyclin T expression as a favorable prognostic factor in treating gastric gastrointestinal stromal tumors |
| Q37992154 | RNA polymerase II elongation control |
| Q34960186 | RNA polymerase II transcription elongation control |
| Q35826285 | Regulation of cyclin T1 and HIV-1 Replication by microRNAs in resting CD4+ T lymphocytes. |
| Q64259746 | Regulation of cyclin T1 during HIV replication and latency establishment in human memory CD4 T cells |
| Q24552532 | Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter |
| Q38111619 | Restrictions to HIV-1 replication in resting CD4+ T lymphocytes |
| Q40375929 | SUN2 Silencing Impairs CD4 T Cell Proliferation and Alters Sensitivity to HIV-1 Infection Independently of Cyclophilin A. |
| Q35227888 | Selective HDAC inhibition for the disruption of latent HIV-1 infection |
| Q37437860 | Selective control of gene expression by CDK9 in human cells |
| Q36738991 | Serum cyclin-dependent kinase 9 is a potential biomarker of atherosclerotic inflammation |
| Q92216465 | Strength of T cell signaling regulates HIV-1 replication and establishment of latency |
| Q33922921 | T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes. |
| Q93218253 | Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer |
| Q42117931 | The Role of RNA Polymerase II Elongation Control in HIV-1 Gene Expression, Replication, and Latency |
| Q24298498 | The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expression |
| Q39685314 | Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function. |
| Q35550068 | Up-regulation of CDK9 kinase activity and Mcl-1 stability contributes to the acquired resistance to cyclin-dependent kinase inhibitors in leukemia |
| Q36202709 | Use of ATP analogs to inhibit HIV-1 transcription |
| Q40786197 | Visualization of in vivo direct interaction between HIV-1 TAT and human cyclin T1 in specific subcellular compartments by fluorescence resonance energy transfer |
Search more.